Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Apr 14.
Published in final edited form as: Tetrahedron Lett. 2010 Apr 14;51(15):2017–2019. doi: 10.1016/j.tetlet.2010.02.033

Synthesis and In Vitro Evaluation of Taxol oxetane ring D precursors

Rüdiger Kaspera a, Jonathan L Cape b, Juan A Faraldos c, Raymond EB Ketchum a, Rodney B Croteau a
PMCID: PMC2839165  NIHMSID: NIHMS179744  PMID: 20305723

Abstract

A series of potential taxoid substrates was prepared in radiolabelled form to probe in vitro for the oxirane formation step and subsequent ring expansion step to the oxetane (ring D) presumably involved in the biosynthesis of the anticancer agent Taxol. None of the taxoid test substrates underwent transformation in cell-free systems from Taxus suggesting that these surrogates bore substitution patterns inappropriate for recognition or catalysis by the target enzymes, or that taxoid oxiranes and oxetanes arise by independent biosynthetic pathways.


Taxol is an established antineoplastic agent that represents a platform for the development of new, second generation drugs for the treatment of cancers and other diseases.1,2 The supply of Taxol and its immediate precursors, by isolation from Taxus tissues3 or cell cultures4, is expected to be replaced by synthetic biology approaches5,6 necessitating knowledge of the underlying pathway biochemistry. Whereas many of the biosynthetic steps en route to Taxol have been characterized7, the biochemistry of formation of the oxetane D-ring is still uncertain.

The complexity of the Taxol biosynthetic pathway has impeded determination of the timing of oxetane ring formation. Within the proposed 19 distinct enzymatic steps leading to Taxol, oxetane ring formation is anticipated to occur in mid-pathway, presumably following the formation of an acetylated taxadien-2,5,7,9,10,13-hexaol but before the formation of baccatin III, to which the C13-side chain is appended in three steps to complete the pathway to Taxol7,8.

Theoretically feasible reaction mechanisms to account for the formation of the Taxol oxetane ring D have been proposed by several groups.914 Based on an evaluation of known structures of naturally occurring taxoid derivatives, a simple and plausible mechanism leading to the oxetane D-ring of Taxol was first proposed by Potier and colleagues.12 The co-occurrence of epoxy and oxetanyl ester taxoids in Taxus species led the authors to propose an enzyme-mediated acid catalyzed epoxyester/oxetaneester rearrangement mechanism involving protonation of a proposed β4,20-epoxide intermediate, backside attack of a C5-acetate moiety onto C4, and rearrangement to the expanded oxetane ring with the formal migration of the secondary 5α-acetoxy group to the tertiary C4α position of the taxane core (scheme 1, I).

Scheme 1.

Scheme 1

Proposed Pathway to Taxol Oxetane Ring D.

This mechanism is thought to proceed via a reactive 1,3-dioxolan-2-ylium cation, formed by acetate-assisted opening of the protonated β4,20-oxirane ring15, but it could also be formulated as a concerted reaction7 (scheme 1, II).

From a biochemical perspective, the intermediate 4β,20-function (e.g. 4, scheme 2) could be formed from the corresponding double bond by a cytochrome P450 oxygenase or a flavin-dependent monooxygenase, since double bond epoxidations involving these enzyme types have been observed previously.16,17 The subsequent ring expansion from epoxide to oxetane with acetate migration could involve a transferase-type enzyme or a mutase of unknown type; this transformation might also be mediated by a cytochrome P450 oxygenase, as somewhat related rearrangements to cyclic ethers catalyzed by P450-enzymes have been recently reported.18,19

Scheme 2.

Scheme 2

Synthesis of Radiolabeled Surrogates.

To explore the enzymology of the presumed epoxidation and oxetane formation reactions in vitro, a series of accessible substrate surrogates was synthesized in radiolabeled form (scheme 2). Although the precise nature (oxidation and acylation state) of the taxoid substrates involved in these reactions are yet to be discovered, we reasoned that allylic ester 1 could serve as a probe to study the initial oxirane ring formation, and the possibility that the resulting epoxide 2 might be processed further to oxetanyl taxoid 3 by subsequent ester-assisted ring expansion. In addition, the epoxy ester surrogates 6 and 7, displaying a more advance oxidation-acylation state, were thought to be good candidates to test the ester-assisted ring expansion reaction outlined in scheme 1, since oxetanyl taxoids with similar functionalities are known in nature.20 Exhaustive literature searches to evaluate the relative abundances of the several hundred defined taxoids from Taxus species,2023 in combination with a wide range of biochemical studies,7,9,11 have shown that none of the known 4β,20-epoxy taxoids bears a benzoate ester at the C2 position (C2-acetates are common), whereas over three-quarters of the characterized oxetane derivatives do bear a benzoate group at the C2 position.20,21 Based on these structural observations, it is tempting to suggest that 4β,20-epoxy taxoids α-benzoylated at C2 (such as synthesized 7) might be transient intermediates of oxetane ring formation.

Labeled taxusin 1 was prepared by regioselective deacetylation at C13 of 1 using MeLi,24 followed by re-acetylation with tritiated Ac2O.25 Taxusin-β4,20-epoxide 2 was obtained in low yield by peracetic acid epoxidation.26 Commercially available 1-hydroxy baccatin I 4 was prepared, via diol 5b, in radiolabeled form (6) following the C13 deacetylation24/reacetylation25 procedure described for allylic alcohol 1. Benzoate 7 was synthesized by regioselective hydrolysis (K2CO3/MeOH)27 at C2 of 4 affording diol 5a,28 followed by benzoylation of the latter with Bz2O.29 After structural confirmation of the unlabeled compounds, the syntheses of 2 and 7 were carried out with tritiated Ac2O and Bz2O, respectively.

Surrogates (1, 2, 6 and 7) were evaluated as potential substrates for the proposed oxirane and oxetane ring formation reactions in crude, soluble and membranous enzyme preparations from Taxus cells under a broad range of redox-type17,28 and transferase-type29,30 reaction conditions. To rule out possible artefacts from non-enzymatic reactions, incubations of compounds 2, 6 and 7 were initially conducted without or with boiled Taxus cell preparations; both experiments revealed that these epoxy ester surrogates were stable under incubation conditions. Since the oxetane (ring D) formation step en route to Taxol is thought to occur at mid biosynthetic pathway,7,8 the Taxus cell-free preparations were tested for taxoid hydroxylase30 and taxoid acetyl transferase31 activities, confirming their catalytic competency for these early and intermediate pathway transformations. Radio-HPLC or HPLC-MS analysis of the reaction mixtures using authentic standards (e.g. baccatin IV and VI, 8) showed that none of the surrogates employed in the present study was converted to the expected epoxide or oxetane derivatives, hence demonstrating that compounds 1, 2, 6 and 7 did not act as functional substrates under the conditions used herein.

In contrast to previous Taxol biosynthetic studies, in which surrogate substrates were of value in defining the target reaction,32,33 the present case did not yield useful information regarding precursors of taxoid oxiranyl or oxetanyl esters. These negative results suggest that the presumed epoxidation (12) and oxetane formation (23 and 6/78) reactions may require different conditions, or substrates with different substitution patterns to permit recognition and catalysis by the relevant enzymes. Alternatively, these results may indicate that 4β,20-epoxy ester and oxetanyl esters represent two distinct types of advanced taxoids formed by separate biosynthetic routes.

Supplementary Material

01

Acknowledgments

We thank Gregory Helms (NMR measurements), Mark B. Lange (HRMS) for assistance. This investigation was supported by Grant CA-55254 from the National Institutes of Health and by the McIntire-Stennis Project 0967 from the Washington State University Agricultural Research Center.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Supplementary data

Additional NMR data and methods for enzyme preparation are available online.

References

  • 1.Brown DT. In: Taxus - The Genus Taxus. Itokawa H, Lee KH, editors. Taylor & Francis; London, UK: 2003. pp. 387–435. [Google Scholar]
  • 2.Wang X. In: Taxus - The Genus Taxus. Itokawa H, Lee KH, editors. Taylor & Francis; London, UK: 2003. pp. 298–386. [Google Scholar]
  • 3.Kikuchi Y, Yatagai M. In: Taxus - The Genus Taxus; Itokawa H, Lee KH, editors. Taylor & Francis; London, UK: 2003. pp. 151–178. [Google Scholar]
  • 4.Takeya K. Taxus - The Genus Taxus. Taylor & Francis; London, UK: 2003. pp. 134–150. [Google Scholar]
  • 5.Engels B, Dahm P, Jennewein S. Metab Eng. 2008;10:201–6. doi: 10.1016/j.ymben.2008.03.001. [DOI] [PubMed] [Google Scholar]
  • 6.Roberts SC. Nat Chem Biol. 2007;3:387–95. doi: 10.1038/nchembio.2007.8. [DOI] [PubMed] [Google Scholar]
  • 7.Croteau R, Ketchum REB, Long RM, Kaspera R, Wildung MR. Phytochem Rev. 2006;5:433–444. doi: 10.1007/s11101-005-3748-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ketchum REB, Croteau R. In: Plant Metabolomics, Biotechnology in Agriculture and Forestry. Saito K, Dixon R, editors. Springer; Heidelberg, D: 2006. pp. 291–309. [Google Scholar]
  • 9.Floss HG, Mocek U. In: Taxol - Science and Application. Suffness M, editor. CRC Press; Boca Raton, USA: 1995. pp. 191–208. [Google Scholar]
  • 10.Swindell CS, Britcher SF. J Org Chem. 1986;51:793–797. [Google Scholar]
  • 11.Walker K, Ketchum RE, Hezari M, Gatfield D, Goleniowski M, Barthol A, Croteau R. Arch Biochem Biophys. 1999;364:273–9. doi: 10.1006/abbi.1999.1125. [DOI] [PubMed] [Google Scholar]
  • 12.Gueritte-Voegelein F, Guenard D, Potier P. J Nat Prod. 1987;50:9–18. doi: 10.1021/np50049a002. [DOI] [PubMed] [Google Scholar]
  • 13.Giner JL, Li X, Mullins JJ. J Org Chem. 2003;68:10079–86. doi: 10.1021/jo034566s. [DOI] [PubMed] [Google Scholar]
  • 14.Willenbrink D, Tantillo D. J Russ J Gen Chem. 2008;78:723–731. [Google Scholar]
  • 15.Giner JL, Faraldos JA. Helv Chim Acta. 2003;86:3613–3622. [Google Scholar]
  • 16.Abe I, Prestwich GD. In: Comprehensive Natural Product Chemistry. Cane DE, editor. Elsevier; Amsterdam, NL: 1999. pp. 267–298. [Google Scholar]
  • 17.Hallahan DL, Lau SM, Harder PA, Smiley DW, Dawson GW, Pickett JA, Christoffersen RE, O’Keefe DP. Biochim Biophys Acta. 1994;1201:94–100. doi: 10.1016/0304-4165(94)90156-2. [DOI] [PubMed] [Google Scholar]
  • 18.Mizutani M, Todoroki Y. Phytochem Rev. 2006;5:385–404. [Google Scholar]
  • 19.Rontein D, Onillon S, Herbette G, Lesot A, Werck-Reichhart D, Sallaud C, Tissier A. J Biol Chem. 2008;283:6067–75. doi: 10.1074/jbc.M708950200. [DOI] [PubMed] [Google Scholar]
  • 20.Baloglu E, Kingston DG. J Nat Prod. 1999;62:1448–72. doi: 10.1021/np990176i. [DOI] [PubMed] [Google Scholar]
  • 21.Itokawa H. In: Taxus - The Genus Taxus. Itokawa HLKH, editor. Taylor & Francis; London, UK: 2003. pp. 35–78. [Google Scholar]
  • 22.Ketchum RE, Horiguchi T, Qiu D, Williams RM, Croteau RB. Phytochemistry. 2007;68:335–41. doi: 10.1016/j.phytochem.2006.10.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ketchum RE, Rithner CD, Qiu D, Kim YS, Williams RM, Croteau RB. Phytochemistry. 2003;62:901–9. doi: 10.1016/s0031-9422(02)00711-2. [DOI] [PubMed] [Google Scholar]
  • 24.Ketchum REB, Tandon M, Gibson DM, Begley T, Schuler ML. J Nat Prod. 1999;62:1395–1398. doi: 10.1021/np990201k. [DOI] [PubMed] [Google Scholar]
  • 25.Samaranyake G, Neidigh KA, Kingston DGI. J Nat Prod. 1993;56:884–898. doi: 10.1021/np50096a012. [DOI] [PubMed] [Google Scholar]
  • 26.2: Peracetic acid (10 μL, 50 μmol) was added to radiolabeled 1 (5 mg, 10 μmol) dissolved in dry CH2Cl2 (1 mL). The reaction was stirred over night at 6–10 °C. Purification by LC gave epoxide 2 (250 μg, 5%). 1H NMR (CDCl3, 600 MHz) δ 6.02 (1H, d, J = 10.69 Hz, H-10), 5.83 (1H, d, J = 10.69 Hz, H-9), 5.81 (1H, m, overlapping H-13), 4.38 (1H, t, J = 2.57 Hz, H-5), 2.79 (1H, dd, J = 4.92 Hz, 2.13 Hz, H-3), 2.72 (1H, d, J = 3.86 Hz, H-20a), 2.77-2.68 (1H, m, H-14β), 2.42 (1H, d, J = 3.86 Hz, H-20b), 2.16 (3H, s, C(O)CH3 at C5), 2.09 (3H, d, J = 0.95 Hz, CH3-18), 2.08 (3H, s, C(O)CH3 at C13), 2.06 (3H, s, C(O)CH3 at C9), 2.00 (3H, s, C(O)CH3 at C10), 1.95 (1H, m, H-6β), 1.84 (1H, m, H-7β), 1.76 (1H, m, H-1), 1.74 (1H, m, H-6α), 1.71 (1H, m, H-7α), 1.58 (3H, s, CH3-17), 1.52 (1H, m, H-2β), 1.07 (3H, s, CH3-16, overlapping H-14α, through HMQC), 0.97 (3H, s, CH3-19), 0.88 (1H, m, H-2α); HRMS m/z found 543.25572 [M++Na], C28H40O9Na requires 543.25699.
  • 27.Lin HX, Jiang Y, Chen JM, Chen JK, Chen MQ. J Mol Structure. 2005;738:59–65. [Google Scholar]
  • 28.5a: To a solution of 4 (10 mg, 15.4 μmol) in MeOH (1 mL) was added a catalytic amount of K2CO3. After 2 h, aq. sat. NH4Cl (1 mL) was added. The mixture was extracted with AcOEt to give diol 5a (4 mg, 43%) after LC purification. 1H NMR (CDCl3, 600 MHz), δ 6.18 (1H, d, J = 11 Hz, H-10), 6.08 (1H, br m, not resolved, H-13), 5.92 (1H, d, J = 11.1 Hz, H-9), 5.49 (1H, dd, J = 4.5 and 12.1 Hz, H-7), 4.27 (1H, t, J = 3.3 Hz, H-5), 4.20 (1H, d, J = 3.5 Hz, H-2), 3.79 (1H, d, J = 4.8 Hz, Ha-20), 3.68, (1H, s, OH at C1), 3.21 (1H, s, OH at C2), 3.19 (1H, d, J = 3.5 Hz, H-3), 2.56 (1H, dd, J = 9.9, 14.9 Hz, H-14), 2.41 (1H, d, J = 4.8 Hz, Hb-20), 2.19 (3H s, C(O)CH3 at C10), 2.17 (3H, s, CH3-18), 2.15 (1H, m, H-6), 2.09 (3H, s, C(O)CH3 at C7 or 13), 2.08 (3H, s, C(O)CH3 at C7 or 13), 2.04 (3H, s, C(O)CH3 at C9), 1.97 (3H, s, C(O)CH3 at C5), 1.83 (1H, dd, J = 6.2, 15.0 Hz, H-14), 1.78 (1H, br m, H-6), 1.56 (3H, s, CH3), 1.28 (3H, CH3-19), 1.23 (3H, s, CH3). HRMS m/z found 633.25194 [M++Na], C30H42O13Na requires 633.2523.
  • 29.7: Bz2O was prepared as follows: a 200 μL portion of dry benzene containing dry pyridine (16 μL) was supplemented with benzoyl chloride (7.2 μL) and stirred for 10 min. 7.5 mg benzoic acid (8.0 mg, 62.5 μmol), or 4-[3H]-benzoic acid [450 μCi] for radiolabeling) in benzene was added in portions over 5 min period. After 10 min, the reaction mixture was diluted with CH2Cl2 (1 mL) and filtered through a SiO2-column to elute pure benzoic anhydride. A stoichiometric amount of Bz2O in CH2Cl2 (0.5 mL) and DMAP (1 mg) in CH2Cl2 (0.5 mL) were added to 5a (2.0 mg, 3.3 μmol). The resulting solution was stirred at room temp. over night. H2O was added, and the mixture was extracted with EtOAc. Purification by LC gives benzoate 7 in 5%. 1H NMR (CDCl3, 600 MHz), δ 7.95 (2H, d, J= 8.5 Hz, benzoyl ortho-H), 7.58 (1H t, J= 7.34 Hz, benzoyl para-H), 7.46 (2H, t, J= 7.8 Hz, benzoyl meta-H), 6.26 (1H, d, J= 10.9 Hz, H-10), 6.14 (1H, d, J=11.3 Hz, H-9), 6.13 (1H, m, H-13, overlapping with C9), 5.79 (1H, d, J=3.4 Hz, H-2), 5.53 (1H, dd, J= 4.4, 12.0 Hz, H-7), 4.20 (1H, t, J= 3.1 Hz, H-5), 3.59 (1H, d, J= 4.7 Hz, H-20a), 3.32 (1H, d, J= 3.6 Hz, H-3), 2.65 (1H, dd, J= 9.8, 14.6 Hz, Hβ-14), 2.30 (1H, d, J= 5.0 Hz, H-20b), 2.26 (3H, s, CH3-18), 2.22 (3H, s, C(O)CH3 at C-10), 2.14 (3H, s, C(O)CH3 at C-13), 2.14 (Hβ-6, through HMQC, covered in 1H-NMR), 2.10 (3H, s, C(O)CH3 at C7), 2.08 (3H, s, C(O)CH3 at C9), 2.07 (m, Hα-14, through HMQC), 2.02 (3H, s, C(O)CH3 at C5), (1H, ddd, J= 3.1, 3.9, 14.8, Hα-6), 1.716 (3H, s, CH3-16), 1.36 (3H, s, CH3-19), 1.26 (3H, s, CH3-17); HRMS m/z found 737.27884 [M + Na], C37H46O14Na requires 737.27853.
  • 30.Wheeler AL, Long RM, Ketchum RE, Rithner CD, Williams RM, Croteau R. Arch Biochem Biophys. 2001;390:265–78. doi: 10.1006/abbi.2001.2377. [DOI] [PubMed] [Google Scholar]
  • 31.Walker K, Croteau R. Proc Natl Acad Sci U S A. 2000;97:583–7. doi: 10.1073/pnas.97.2.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Chau M, Croteau R. Arch Biochem Biophys. 2004;427:48–57. doi: 10.1016/j.abb.2004.04.016. [DOI] [PubMed] [Google Scholar]
  • 33.Walker K, Croteau R. Proc Natl Acad Sci U S A. 2000;97:13591–6. doi: 10.1073/pnas.250491997. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES